Results 61 to 70 of about 4,714 (209)
Oral progesterone for the prevention of recurrent preterm birth: systematic review and metaanalysis [PDF]
, 2019 Objective The purpose of this study was to perform a systematic review and metaanalysis of randomized controlled trials on oral progesterone compared with placebo or other interventions for preterm birth prevention in singleton pregnancies with ...
Ashoush, Sherif +6 more
core +1 more source
Molecular Oncology, Volume 20, Issue 1, Page 117-133, January 2026.The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat +18 more
wiley +1 more source
Menopause, menopausal therapies and asymmetric dimethylarginine, an emerging cardiovascular risk factor [PDF]
, 2007 Oestrogenen en asymmetrische dimethylarginine Hart- en vaatziekten (HVZ) vormen de belangrijkste doodsoorzaak in de Westerse wereld. Premenopauzale vrouwen hebben een lager risico op HVZ dan mannen van dezelfde leeftijd, maar na de menopauze neemt de ...
Verhoeven, M.O.
core +2 more sources
The progestin levonorgestrel affects sex differentiation in zebrafish at environmentally relevant concentrations [PDF]
, 2015 Synthetic progestins have become widespread environmental contaminants and may cause adverse effects on fish. In the present study, we investigated the effects of levonorgestrel (LNG) on sex differentiation in zebrafish (Danio rerio).
Guo, Yongyong +3 more
core +1 more source
Advanced Science, Volume 13, Issue 2, 9 January 2026.Natural killer cells, central to anti‐tumor defense, undergo unexpected reprogramming within the tumor microenvironment. Instead of producing IFN‐γ and TNF‐α, they elevate amphiregulin, a tumor‐promoting factor. This shift is linked to glucocorticoid receptor activity and prostaglandin signaling.
Qin Wei +8 more
wiley +1 more source
Age-related diseases and menopausal hormone therapy – focus on progestogens
Лечащий Врач, 2022 Hormone therapy is the most effective treatment for menopausal symptoms. The benefits of using menopausal hormone therapy outweigh the risks for healthy women. However, the situation is more complicated in women with one or more chronic diseases.
E. N. Kareva
doaj +1 more source
Dydrogesterone use in early pregnancy
Gynecological Endocrinology, 2016 Successful oocyte implantation and a favorable pregnancy outcome rely on optimal progesterone levels. Therefore, progesterone deficiencies associated with infertility and miscarriage have commonly been treated with progestogens that mimic the activity of progesterone.
Mirza, Fadi Ghazi +2 more
openaire +3 more sources
Identifying signals of potentially harmful medications in pregnancy: use of the double false discovery rate method to adjust for multiple testing. [PDF]
, 2018 AIMS: Surveillance of medication use in pregnancy is essential to identify associations between first trimester medications and congenital anomalies (CAs). Medications in the same Anatomical Therapeutic Chemical classes may have similar effects. We aimed
Cavadino, A +2 more
core +2 more sources
Reproductive Medicine and Biology, Volume 25, Issue 1, January/December 2026.ABSTRACT Purpose To evaluate the combined effects of micronized vaginal progesterone (P4) dose and achieved serum P4 levels on reproductive outcomes in hormone replacement therapy–frozen embryo transfer (HRT‐FET) cycles by classifying patients according to both parameters.
Mami Sekiguchi +8 more
wiley +1 more source
Regarding the evidence-based use of micronized progesterone
Репродуктивная эндокринология, 2020 An issue of habitual miscarriage poses a high social importance especially during COVID-19 pandemic. Meanwhile, healthcare workers faced a mass media campaign against using micronized progesterone upon habitual miscarriage, which, as viewed by ...
A. D. Makatsariya +2 more
doaj +1 more source